MicroRNA-26b protects against MASH development in mice and can be efficiently targeted with lipid nanoparticles.
Linsey J. F. Peters, Leonida Rakateli, Rosanna Huchzermeier, Andrea Bonnin-Marquez, Sanne Lidewij Maas, Cheng Lin, Alexander Jans, Yana Geng, Alan R. Gorter, Marion J. Gijbels, Sander S. Rensen, Peter Olinga, Tim Hendrikx, Marcin Jan Krawczyk, Malvina Brisbois, , Emiel P. C. van der Vorst
This paper shows that miR-26b deficiency worsens MASH in mice, and that miR-26b mimic-loaded LNPs can reverse these effects.
bioRxiv · Feb 18, 2024Pathology